PHOSPHOSYNVAX Trademark

Trademark Overview

On Wednesday, July 17, 2019, a trademark application was filed for PHOSPHOSYNVAX with the United States Patent and Trademark Office. The USPTO has given the PHOSPHOSYNVAX trademark a serial number of 88518917. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 13, 2023. This trademark is owned by Agenus Inc.. The PHOSPHOSYNVAX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and biopharmaceutical agents, namely, vaccines, immunotherapeutics, and other therapeutic agents, for the prevention and treatment of human diseases, namely, cancers, autoimmune disorders, infectious disease, transplant rejection, and inflammatory disease
phosphosynvax

General Information

Serial Number88518917
Word MarkPHOSPHOSYNVAX
Filing DateWednesday, July 17, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 13, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 12, 2019

Trademark Statements

Goods and ServicesPharmaceutical and biopharmaceutical agents, namely, vaccines, immunotherapeutics, and other therapeutic agents, for the prevention and treatment of human diseases, namely, cancers, autoimmune disorders, infectious disease, transplant rejection, and inflammatory disease

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 25, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAgenus Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLexington, MA 024217305
Party NameAgenus Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLexington, MA 024217305

Trademark Events

Event DateEvent Description
Monday, February 13, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 13, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, July 19, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 18, 2022SOU EXTENSION 5 GRANTED
Thursday, June 30, 2022SOU EXTENSION 5 FILED
Monday, July 18, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, June 30, 2022SOU TEAS EXTENSION RECEIVED
Thursday, January 6, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 4, 2022SOU EXTENSION 4 GRANTED
Tuesday, January 4, 2022SOU EXTENSION 4 FILED
Tuesday, January 4, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, July 6, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 2, 2021SOU EXTENSION 3 GRANTED
Friday, July 2, 2021SOU EXTENSION 3 FILED
Friday, July 2, 2021SOU TEAS EXTENSION RECEIVED
Saturday, January 9, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 7, 2021SOU EXTENSION 2 GRANTED
Thursday, January 7, 2021SOU EXTENSION 2 FILED
Thursday, January 7, 2021SOU TEAS EXTENSION RECEIVED
Thursday, July 9, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 7, 2020SOU EXTENSION 1 GRANTED
Tuesday, July 7, 2020SOU EXTENSION 1 FILED
Tuesday, July 7, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, January 7, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 12, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 12, 2019PUBLISHED FOR OPPOSITION
Wednesday, October 23, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, October 3, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 3, 2019ASSIGNED TO EXAMINER
Thursday, July 25, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, July 20, 2019NEW APPLICATION ENTERED

Related Keywords

phosphosynvax disease agents namely cancers disorders autoimmune infectious transplant inflammatory rejection